TNSN02003A1 - Association d'un antagoniste des recepteurs d'histamine h1 et d'un antagoniste selectif des recepteurs d'histamine h4, et composition la contenant. - Google Patents
Association d'un antagoniste des recepteurs d'histamine h1 et d'un antagoniste selectif des recepteurs d'histamine h4, et composition la contenant.Info
- Publication number
- TNSN02003A1 TNSN02003A1 TNTNSN02003A TNSN02003A TNSN02003A1 TN SN02003 A1 TNSN02003 A1 TN SN02003A1 TN TNSN02003 A TNTNSN02003 A TN TNSN02003A TN SN02003 A TNSN02003 A TN SN02003A TN SN02003 A1 TNSN02003 A1 TN SN02003A1
- Authority
- TN
- Tunisia
- Prior art keywords
- histamine
- antagonist
- combination
- composition containing
- same
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Otolaryngology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
L'INVENTION PROPOSE UNE ASSOCIATION (a) D'UN ANTAGONISTE DES RECEPTEURS D'HISTAMINE H1 ET (b) D'UN ANTAGONISTE QUI EST AU MOINS 10 FOIS PLUS SELECTIF POUR LE RECEPTEUR D'HISTAMINE H4 QUE POUR LE RECEPTEUR D'HISTAMINE H3. ELLE CONCERNE EGALEMENT UNE COMPOSITION PHARMACEUTIQUE LA CONTENANT. APPLICATION : UTILISATION DE CETTE ASSOCIATION OU COMPOSITION POUR LE TRAITEMENT DE DIVERSES MALADIES, TELLES QUE LA RHINITE ALLERGIQUE OU L'ASTHME.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0101223.6A GB0101223D0 (en) | 2001-01-17 | 2001-01-17 | Histamine receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TNSN02003A1 true TNSN02003A1 (fr) | 2005-12-23 |
Family
ID=9906993
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNTNSN02003A TNSN02003A1 (fr) | 2001-01-17 | 2002-01-16 | Association d'un antagoniste des recepteurs d'histamine h1 et d'un antagoniste selectif des recepteurs d'histamine h4, et composition la contenant. |
Country Status (32)
| Country | Link |
|---|---|
| EP (1) | EP1353657A1 (fr) |
| JP (1) | JP2004517883A (fr) |
| KR (1) | KR20030069216A (fr) |
| CN (1) | CN1486178A (fr) |
| AP (1) | AP2002002401A0 (fr) |
| AR (1) | AR032101A1 (fr) |
| BG (1) | BG107834A (fr) |
| BR (1) | BR0206502A (fr) |
| CA (1) | CA2435121A1 (fr) |
| CR (1) | CR6983A (fr) |
| CZ (1) | CZ20031853A3 (fr) |
| DO (1) | DOP2002000325A (fr) |
| EA (1) | EA200300537A1 (fr) |
| EC (1) | ECSP034692A (fr) |
| EE (1) | EE200300335A (fr) |
| GB (1) | GB0101223D0 (fr) |
| GT (1) | GT200200003A (fr) |
| HU (1) | HUP0302767A2 (fr) |
| IL (1) | IL156087A0 (fr) |
| IS (1) | IS6818A (fr) |
| MA (1) | MA26980A1 (fr) |
| MX (1) | MXPA03006408A (fr) |
| NO (1) | NO20033223D0 (fr) |
| OA (1) | OA12440A (fr) |
| PA (1) | PA8537101A1 (fr) |
| PL (1) | PL362793A1 (fr) |
| PY (1) | PY0200477A (fr) |
| SK (1) | SK8572003A3 (fr) |
| SV (1) | SV2003000849A (fr) |
| TN (1) | TNSN02003A1 (fr) |
| WO (1) | WO2002056871A2 (fr) |
| ZA (1) | ZA200304180B (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030133931A1 (en) * | 2001-12-21 | 2003-07-17 | Robin Thurmond | Use of histamine H4 receptor antagonist for the treatment of inflammatory responses |
| EP1545596A4 (fr) * | 2002-09-06 | 2005-12-28 | Janssen Pharmaceutica Nv | Utilisation de modulateurs du recepteur h4 de l'histamine pour le traitement des allergies et de l'asthme |
| WO2004066960A2 (fr) * | 2003-01-28 | 2004-08-12 | Schering Corporation | Combinaison d'antagonistes des recepteurs h1, h3 et h4 en vue du traitement d'inflammations pulmonaires allergiques et non allergiques, de congestions et de rhinites allergiques |
| US8236786B2 (en) | 2008-08-07 | 2012-08-07 | Pulmagen Therapeutics (Inflammation) Limited | Respiratory disease treatment |
| WO2013151982A1 (fr) | 2012-04-03 | 2013-10-10 | Arena Pharmaceuticals, Inc. | Méthodes et composés utiles pour traiter le prurit, et procédés d'identification desdits composés |
| HUE039713T2 (hu) | 2012-06-08 | 2019-02-28 | Sensorion | H4 receptor inhibitorok tinnitus kezelésére |
| CN119823227B (zh) * | 2025-01-14 | 2025-07-04 | 广州迪卡德营养科技有限公司 | 一种益生菌的制备方法及其在治疗过敏性鼻炎中的用途 |
-
2001
- 2001-01-17 GB GBGB0101223.6A patent/GB0101223D0/en not_active Ceased
-
2002
- 2002-01-10 EA EA200300537A patent/EA200300537A1/ru unknown
- 2002-01-10 JP JP2002557379A patent/JP2004517883A/ja not_active Withdrawn
- 2002-01-10 CA CA002435121A patent/CA2435121A1/fr not_active Abandoned
- 2002-01-10 IL IL15608702A patent/IL156087A0/xx unknown
- 2002-01-10 HU HU0302767A patent/HUP0302767A2/hu unknown
- 2002-01-10 KR KR10-2003-7009493A patent/KR20030069216A/ko not_active Ceased
- 2002-01-10 BR BR0206502-9A patent/BR0206502A/pt not_active IP Right Cessation
- 2002-01-10 EE EEP200300335A patent/EE200300335A/xx unknown
- 2002-01-10 WO PCT/IB2002/000042 patent/WO2002056871A2/fr not_active Ceased
- 2002-01-10 OA OA1200300174A patent/OA12440A/en unknown
- 2002-01-10 CZ CZ20031853A patent/CZ20031853A3/cs unknown
- 2002-01-10 EP EP02732099A patent/EP1353657A1/fr not_active Withdrawn
- 2002-01-10 PL PL02362793A patent/PL362793A1/xx not_active Application Discontinuation
- 2002-01-10 SK SK857-2003A patent/SK8572003A3/sk unknown
- 2002-01-10 CN CNA028036840A patent/CN1486178A/zh active Pending
- 2002-01-10 MX MXPA03006408A patent/MXPA03006408A/es unknown
- 2002-01-11 DO DO2002000325A patent/DOP2002000325A/es unknown
- 2002-01-14 PA PA20028537101A patent/PA8537101A1/es unknown
- 2002-01-14 PY PY200200200477A patent/PY0200477A/es unknown
- 2002-01-16 GT GT200200003A patent/GT200200003A/es unknown
- 2002-01-16 TN TNTNSN02003A patent/TNSN02003A1/fr unknown
- 2002-01-16 SV SV2002000849A patent/SV2003000849A/es not_active Application Discontinuation
- 2002-01-16 AR ARP020100145A patent/AR032101A1/es not_active Application Discontinuation
- 2002-01-17 AP APAP/P/2002/002401A patent/AP2002002401A0/en unknown
-
2003
- 2003-05-15 IS IS6818A patent/IS6818A/is unknown
- 2003-05-21 BG BG107834A patent/BG107834A/bg unknown
- 2003-05-22 CR CR6983A patent/CR6983A/es not_active Application Discontinuation
- 2003-05-29 ZA ZA200304180A patent/ZA200304180B/en unknown
- 2003-07-11 MA MA27233A patent/MA26980A1/fr unknown
- 2003-07-16 NO NO20033223A patent/NO20033223D0/no not_active Application Discontinuation
- 2003-07-17 EC EC2003004692A patent/ECSP034692A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL156087A0 (en) | 2003-12-23 |
| SV2003000849A (es) | 2003-01-13 |
| AP2002002401A0 (en) | 2002-03-31 |
| MXPA03006408A (es) | 2003-10-15 |
| PL362793A1 (pl) | 2004-11-02 |
| BR0206502A (pt) | 2003-10-21 |
| CR6983A (es) | 2003-11-25 |
| GB0101223D0 (en) | 2001-02-28 |
| SK8572003A3 (en) | 2004-07-07 |
| NO20033223L (no) | 2003-07-16 |
| PY0200477A (es) | 2004-06-01 |
| BG107834A (bg) | 2004-01-30 |
| PA8537101A1 (es) | 2002-08-29 |
| CN1486178A (zh) | 2004-03-31 |
| KR20030069216A (ko) | 2003-08-25 |
| MA26980A1 (fr) | 2004-12-20 |
| EE200300335A (et) | 2003-12-15 |
| CA2435121A1 (fr) | 2002-07-25 |
| ZA200304180B (en) | 2004-06-15 |
| DOP2002000325A (es) | 2003-01-31 |
| ECSP034692A (es) | 2003-08-29 |
| AR032101A1 (es) | 2003-10-22 |
| EP1353657A1 (fr) | 2003-10-22 |
| WO2002056871A2 (fr) | 2002-07-25 |
| OA12440A (en) | 2006-05-22 |
| JP2004517883A (ja) | 2004-06-17 |
| IS6818A (is) | 2003-05-15 |
| GT200200003A (es) | 2002-08-19 |
| NO20033223D0 (no) | 2003-07-16 |
| EA200300537A1 (ru) | 2004-02-26 |
| HUP0302767A2 (hu) | 2003-11-28 |
| CZ20031853A3 (cs) | 2004-07-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TNSN02018A1 (fr) | COMPOSITIONS COMPRENANT UN AGONISTE INVERSE DE GABAa, ET UN AGONISTE PARTIEL DES RECEPTEURS DE NICOTINE, UN OESTROGENE, UN MODULATEUR SELECTIF DES RECEPTEURS D'OESTROGENE OU DE LA VITAMINE E | |
| TNSN01068A1 (fr) | Compositions pharmaceutiques pour le traitement de maladies comportant un dysfonctionnement cognitif | |
| TNSN01053A1 (fr) | Compositions nouvelles comprenant un agoniste partiel des recepteurs de nicotine et un agent analgesique | |
| DE69531998D1 (de) | Steroidrezeptor-modulator verbindungen und methoden | |
| TR200102021T2 (tr) | TWEAK ve TWEAK reseptörü antagonistleri ve bunların imünolojik bozuklukların iyileştirilmesi için kullanımları | |
| ATE300533T1 (de) | 1,2,3,4-tetrahydroisochinolin-derivate als urotensin ii rezeptor-antagonisten | |
| MA27028A1 (fr) | Agoniste de recepteur d'adenosine a2a et agent anticholinergique en association pour le traitement de maladies obstructives des voies aeriennes | |
| EP1109542A4 (fr) | Antagonistes nitroses et nitrosyles des recepteurs alpha-adrenergiques, compositions et methodes d'utilisation | |
| TNSN00183A1 (fr) | COMPOSITIONS COMPRENANT LE POLYPEPTIDE IL-1ra ET UN INHIBITEUR DE MATURATION ET DE LIBERATION DE IL-1 ET METHODES DE TRAITEMENT LES UTILISANT | |
| TNSN98017A1 (fr) | Derives de sulfonyluree, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
| MA31016B1 (fr) | Composes de diazepan substitues comme antagonistes des recepteurs de l'orexine. | |
| BR9813957A (pt) | Uso de antagonistas da vasopressina | |
| NO20035025L (no) | Anvendelse av osteopontin for behandling og/eller for a hindre nevrologiske sykdommer, samt farmasoytisk sammensetning omfattende osteopontin eller en antagonist med osteopontinaktivitet. | |
| ID29095A (id) | Antagonis mglur5 untuk pengobatan rasa sakit dan kegelisahan | |
| MA29487B1 (fr) | Preparation de type emulsion stable | |
| ATE237321T1 (de) | 20-hete antagonisten und agonisten | |
| BR0015980A (pt) | Agente para profilaxia ou tratamento do glaucoma, e, uso de um antagonista de angiotensina ii | |
| ATE266420T1 (de) | Kombinationspräparat, das selektive nmda nr2b- antagonisten und cox-2 inhibitoren enthält | |
| ATE348812T1 (de) | Chinolin- und chinazolinderivate als antagonisten des corticotropin freisetzenden faktors (crf) | |
| MY135916A (en) | Use of certain affinity nmda antagonists as antidepressants | |
| YU39201A (sh) | Upotreba 1-arilpirazola za pripremanje oralnog sredstva za suzbijanje parazita | |
| EP1468288A4 (fr) | Compositions et methodes pour le diagnostic precoce precis de la grossesse | |
| MA26980A1 (fr) | Antagonistes des recepteurs d'histamine. | |
| BR0213183A (pt) | Uso de ativadores gp130 em neuropatia diabética | |
| BR0212582A (pt) | Combinação |